Risk of colitis in immune checkpoint inhibitors and in chemotherapy/placebo for solid tumors: a systematic review and meta-analysis

BACKGROUND: We conducted a systematic review and meta-analysis in an attempt to evaluate the risk of colitis in immune checkpoint inhibitors (ICIs) and in chemotherapy/placebo for solid tumors. METHODS: Embase and PubMed were searched with specific keywords of our concern. Collected data were proces...

Descripción completa

Detalles Bibliográficos
Autores principales: Wei, Wei, Ding, Yun, He, Jiajia, Wu, Jun
Formato: Online Artículo Texto
Lenguaje:English
Publicado: AME Publishing Company 2020
Materias:
Original Article
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8798055/
https://www.ncbi.nlm.nih.gov/pubmed/35117786
http://dx.doi.org/10.21037/tcr-19-2872

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8798055/
https://www.ncbi.nlm.nih.gov/pubmed/35117786
http://dx.doi.org/10.21037/tcr-19-2872

Ejemplares similares